Literature DB >> 15303003

Pseudo-glutarylcarnitinaemia in medium-chain acyl-CoA dehydrogenase deficiency detected by tandem mass spectrometry newborn screening.

N Napolitano1, V Wiley, J J Pitt.   

Abstract

As well as characteristic increases in C(8) carnitine, dried blood spot samples from 11 newborns with medium-chain acyl-CoA dehydrogenase deficiency detected by tandem mass spectrometry screening using butyl esters showed apparent increases in glutarylcarnitine (m / z 388 signals). In four of the newborns in which it was measured, apparent increases in malonylcarnitine (m / z 360) were also detected. It was shown that the apparent increases were caused by interfering acylcarnitines, putatively identified as hydroxyoctanoylcarnitine and hydroxydecanoylcarnitine, respectively, using alternative derivatives for tandem mass spectrometry. Levels of the two abnormal carnitines correlated with C(8) carnitine levels and normalized with repeat testing in 10 cases. These results indicated that the abnormal carnitines were significantly elevated only during periods of increased fatty acid catabolism, as may occur in the immediate postnatal period.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15303003     DOI: 10.1023/B:BOLI.0000037343.90450.8d

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  17 in total

Review 1.  The application of tandem mass spectrometry to neonatal screening for inherited disorders of intermediary metabolism.

Authors:  Donald H Chace; Theodore A Kalas; Edwin W Naylor
Journal:  Annu Rev Genomics Hum Genet       Date:  2002-04-15       Impact factor: 8.929

2.  Newborn screening with tandem mass spectrometry: 12 months' experience in NSW Australia.

Authors:  V Wiley; K Carpenter; B Wilcken
Journal:  Acta Paediatr Suppl       Date:  1999-12

3.  Postnatal changes in neonatal acylcarnitine profile.

Authors:  J Meyburg; A Schulze; D Kohlmueller; O Linderkamp; E Mayatepek
Journal:  Pediatr Res       Date:  2001-01       Impact factor: 3.756

4.  Abnormal urinary excretion of unsaturated dicarboxylic acids in patients with medium-chain acyl-CoA dehydrogenase deficiency.

Authors:  K Y Tserng; S J Jin; D S Kerr; C L Hoppel
Journal:  J Lipid Res       Date:  1990-05       Impact factor: 5.922

5.  Evaluation of newborn screening for medium chain acyl-CoA dehydrogenase deficiency in 275 000 babies.

Authors:  K Carpenter; V Wiley; K G Sim; D Heath; B Wilcken
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-09       Impact factor: 5.747

6.  Identification of new medium-chain acylcarnitines present in urine of a patient with medium-chain acyl-CoA dehydrogenase deficiency.

Authors:  R Libert; F Van Hoof; M Thillaye; M F Vincent; M C Nassogne; V Stroobant; E de Hoffmann; A Schanck
Journal:  J Inherit Metab Dis       Date:  1999-02       Impact factor: 4.982

7.  Screening for medium chain acyl-CoA dehydrogenase deficiency using electrospray ionisation tandem mass spectrometry.

Authors:  P T Clayton; M Doig; S Ghafari; C Meaney; C Taylor; J V Leonard; M Morris; A W Johnson
Journal:  Arch Dis Child       Date:  1998-08       Impact factor: 3.791

8.  Novel glycine conjugates in medium-chain acyl-CoA dehydrogenase deficiency.

Authors:  J J Pitt
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

9.  Episodic hypoglycemia with psi-hydroxy fatty acid excretion.

Authors:  E Colle; O A Mamer; J A Montgomery; J D Miller
Journal:  Pediatr Res       Date:  1983-02       Impact factor: 3.756

10.  Diagnosis of inborn errors of metabolism from blood spots by acylcarnitines and amino acids profiling using automated electrospray tandem mass spectrometry.

Authors:  M S Rashed; P T Ozand; M P Bucknall; D Little
Journal:  Pediatr Res       Date:  1995-09       Impact factor: 3.756

View more
  5 in total

1.  An improved LC-MS/MS method for the detection of classic and low excretor glutaric acidemia type 1.

Authors:  Tereza Moore; Anthony Le; Tina M Cowan
Journal:  J Inherit Metab Dis       Date:  2011-10-18       Impact factor: 4.982

2.  Guideline for the diagnosis and management of glutaryl-CoA dehydrogenase deficiency (glutaric aciduria type I).

Authors:  S Kölker; E Christensen; J V Leonard; C R Greenberg; A B Burlina; A P Burlina; M Dixon; M Duran; S I Goodman; D M Koeller; E Müller; E R Naughten; E Neumaier-Probst; J G Okun; M Kyllerman; R A Surtees; B Wilcken; G F Hoffmann; P Burgard
Journal:  J Inherit Metab Dis       Date:  2007-01-03       Impact factor: 4.982

Review 3.  Neonatal screening for glutaric aciduria type I: strategies to proceed.

Authors:  M Lindner; S Ho; J Fang-Hoffmann; G F Hoffmann; S Kölker
Journal:  J Inherit Metab Dis       Date:  2006 Apr-Jun       Impact factor: 4.982

4.  False-positive newborn screening mimicking glutaric aciduria type I in infants with renal insufficiency.

Authors:  Julia B Hennermann; Sylvia Roloff; Jutta Gellermann; Annette Grüters; Jeannette Klein
Journal:  J Inherit Metab Dis       Date:  2009-12-23       Impact factor: 4.982

Review 5.  Diagnosis and management of glutaric aciduria type I--revised recommendations.

Authors:  Stefan Kölker; Ernst Christensen; James V Leonard; Cheryl R Greenberg; Avihu Boneh; Alberto B Burlina; Alessandro P Burlina; Marjorie Dixon; Marinus Duran; Angels García Cazorla; Stephen I Goodman; David M Koeller; Mårten Kyllerman; Chris Mühlhausen; Edith Müller; Jürgen G Okun; Bridget Wilcken; Georg F Hoffmann; Peter Burgard
Journal:  J Inherit Metab Dis       Date:  2011-03-23       Impact factor: 4.982

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.